Form D · Other Health Care

Lyo Lux Holdings, Inc.

New York, NY · CIK 0001706974

Offering snapshot reported Feb 25, 2020 · SEC filing

Reported sold
Yet to sell
Offering amount: $24.6M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors12 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 25, 2020AmendmentYet to sellNo comparison11SEC filing
Feb 25, 2019AmendmentYet to sellNo comparison12SEC filing
Jan 15, 2019Initial$350,000No comparison1SEC filing
Nov 2, 2017AmendmentYet to sellNo comparison0SEC filing
Aug 25, 2017AmendmentYet to sellNo comparison0SEC filing
Aug 4, 2017InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Option to acquire, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-292198
The type of security includes options and the underlying shares of common stock issuable upon exercise of the options.

Source: Form D, filed Feb 25, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Claes Glassell Director
Matthew J. Halvorsen Director
Marcel Lacaze Director
Henry Minello Director, Executive
Laura O'donnell Director, Executive
Matthew Perry Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
320 Park Avenue 28 Th Floor
New York, NY, 10022